Menopause Anxiety and Depression; How Food Can Help?
DOI:
https://doi.org/10.3889/oamjms.2021.5555Keywords:
Anxiety, Depression, Fatty acids, Menopause, PhytoestrogenAbstract
BACKGROUND: Anxiety and depression are reported as two major frequent and chief complaints among peri-menopausal women in several societies.
AIM: The objective of the study was to study the effect of using two dietary supplements to beat depression and anxiety associated with menopause.
SUBJECTS AND METHODS: Sixty-six volunteers’ menopausal women participated on the study for 8 weeks, 35 subjects consumed daily cookies prepared mainly from soya flour and flaxseed, and 31 females consumed daily a blend composed mainly of raw unroasted peanut and raw sesame. Follow-up was performed with menopause rating scale, anxiety score, depression score, and biochemical parameters.
RESULTS: Soya cookies were rich in plant-based protein and total phenols while blend was a good source of unsaturated fatty acid. Blend consumers showed significant percentage reduction in beck anxiety score and beck depression score after intervention, more than cookies consumers group. The anthropometrics parameters were statistical significant changed on both groups, more on the group who consumed the soya cookies. Soya cookies demonstrated an anti-inflammatory effect, while blend had an antioxidant and anti-inflammatory effects as was shown on the serum assay of interleukin-6 and malondialdehyde as an inflammatory marker and an antioxidant marker, respectively.
CONCLUSION: From the results, it can be concluded that the supplementation of products enriched with unsaturated fatty acid was more beneficial to slow down the psychological menopause symptoms than natural estrogen rich product consumption.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Unsal A, Tozun M, Ayranci U. Prevalence of depression among postmenopausal women and related characteristics. Climacteric. 2011;14(2):244-51. https://doi.org/10.3109/13697137.2010.510912 PMid:20964551 DOI: https://doi.org/10.3109/13697137.2010.510912
Cohen L, Soares C, Vitonis A, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63(4):386-90. https://doi.org/10.1001/archpsyc.63.4.385 PMid:16585467 DOI: https://doi.org/10.1001/archpsyc.63.4.385
Graziottin A, Banerji V, Hall G. Vasomotor symptoms and neurovegetative comorbidities on the menopause: Insights from an Italian quantitative research. Gynecol Endocrinol. 2019;35(9):762- 6. https://doi.org/10.1080/09513590.2019.1582625 PMid:31266379 DOI: https://doi.org/10.1080/09513590.2019.1582625
World health Organization. Depression and other Common Mental Disorders: Global Health Estimates Booklet. Geneva: World health Organization; 2017. https://doi.org/10.1037/e400972004-001 5. Joffe H, De Wit A, Coborn J, Crawford S, Freeman M, Wiley A, et al. Impact of estradiol variability and progesterone on mood in perimenopausal women with depressive symptoms. J Clin Endocrinol Metab. 2020;105(3):e642-50. https://doi.org/10.1210/clinem/dgz181 PMid:31693131 DOI: https://doi.org/10.1210/clinem/dgz181
Cakir T, Goktas B, Mutlu M, Mutlu I, Bilgihan A, Erdem M, et al. Advanced oxidation protein products and malondialdehyde, the new biological markers of oxidative stress are elevated in postmenopausal women. Ginekol Pol. 2016;87(5):321-5. https://doi.org/10.5603/gp.2016.0001 PMid:27304645 DOI: https://doi.org/10.5603/GP.2016.0001
Natari RB, Clavarino AM, McGuire TM, Dingle KD, Hollingworth SA. The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: A systematic review of longitudinal studies. Menopause. 2018;25(1):109-20. https://doi.org/10.1097/gme.0000000000000949 PMid:28719420 DOI: https://doi.org/10.1097/GME.0000000000000949
Augoulea A, Moros M, Lykeridou A, Kaparos G, Lyberi R, Panoulis K. Psychosomatic and vasomotor symptom changes during transition to menopause. Prz Menopauzalny. 2019;18(2):110-5. https://doi.org/10.5114/pm.2019.86835 PMid:31485208 DOI: https://doi.org/10.5114/pm.2019.86835
Messina M. A brief historical overview of the past two decades of soy and isoflavones research. J Nutr. 2010;140(7):1350S-4S. https://doi.org/10.3945/jn.109.118315 PMid:20484551 DOI: https://doi.org/10.3945/jn.109.118315
Nicoletti M. Nutraceuticals and botanicals: overview and perspectives. Int J Food Sci Nutr. 2012;63(1):2-6. PMid:22360273 DOI: https://doi.org/10.3109/09637486.2011.628012
Fouad S, El Shebini S, Moaty M, Ahmed N, Hussein A, El Gendy A, et al. Nutritional supplement prepared from whole meal wheat flour, soya bean flour, flaxseed and anise seeds for alleviating the menopausal symptoms. J Biol Sci. 2018;18(7):381-8. https://doi.org/10.3923/jbs.2018.381.388 DOI: https://doi.org/10.3923/jbs.2018.381.388
Moaty MI, Fouad S, El Shebini S, Kazem YK, Ahmed NH, Mohamed MS, et al. Serum ceramide kinase as a biomarker of cognitive functions and the effect of using two slimming dietary therapies in obese middle aged females. Open Access Maced J Med Sci. 2015;3(1):18-25. https://doi.org/10.3889/oamjms.2015.030 PMid:27275191 DOI: https://doi.org/10.3889/oamjms.2015.030
Comhaire FH, Depypere HT. Hormones, herbal preparation and nutraceuticals for better life after the menopause: Part II. Climateric. 2015;18:364-71. https://doi.org/10.3109/13697137.2014.985646 PMid:25668332 DOI: https://doi.org/10.3109/13697137.2014.985646
American Association for Clinical Chemistry. Approved Methods of Analysis. 10th ed. St. Paul, MN, USA: American Association of Cereal Chemists; 2000. p. 1200.
AOAC International. In: Horwitz W, editors. Official Methods of Analysis of AOAC International. 17th ed. Gaithersburg, Maryland: AOAC International; 2000.
Wirasnita R, Hadibarata T, Novelina YM, Yusoff AR, Yusop ZA. Modified methylation method to determine fatty acid content by gas chromatography. Bull Korean Chem Soc. 2013;34(11):3239- 42. https://doi.org/10.5012/bkcs.2013.34.11.3239 DOI: https://doi.org/10.5012/bkcs.2013.34.11.3239
Jelliffe D. The Assessment of the Nutritional Status of the Community. Geneva: World Health Organization, Monograph, Series No. 53; 1966. p. 63-9.
Schneider H, Heinemann L, Rosemeier H, Potthoff P, Behre H. The menopause rating scale (MRS): Reliability of scores of menopausal complaints. Climacteric. 2000;3:59-64. https://doi.org/10.3109/13697130009167600 DOI: https://doi.org/10.3109/13697130009167600
Beck A, Epstein N, Brown G, Steer R. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893-7. https://doi.org/10.1037/0022-006x.56.6.893 PMid:3204199 DOI: https://doi.org/10.1037/0022-006X.56.6.893
Beck A, Steer R, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3): 588-97. https://doi.org/10.1207/s15327752jpa6703
Steer R, Ball R, Ranieri W, Beck A. Dimensions of the beck depression inventory-II in clinically depressed outpatients. J Clin Psychol. 1999;55(1):117-28. https://doi.org/10.1002/(sici)1097-4679(199901)55:1<117::aid-jclp12>3.0.co;2-a PMid:10100838 DOI: https://doi.org/10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A
Ethardt J. Nutrition Surveys and Calculations, Guidelines, Software and Additional Information 2012; Nutri Survey Program; 2007. Available from: http://www.nutrisurvey.de/ ena2011. [Last accessed on 2010 April 02]
Ratcliffe W, Carter G, Dowsett M, Hillier S, Middle J, Reed M. Oestradiol assays: Applications and guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem. 1988;25(5):466- 83. https://doi.org/10.1177/000456328802500502 PMid:3069043 DOI: https://doi.org/10.1177/000456328802500502
Rebar R, Erickson G, Yen S. Idiopathic premature ovarian failure: Clinical and endocrine characteristics. Fertil Steril. 1982;37(1):35-41. PMid:6800842 DOI: https://doi.org/10.1016/S0015-0282(16)45973-X
Lopez J, Burtis CA, Ashwood ER, Bruns De, editors. Tietz Textbook of Clinical Chemistry and Molecular Diagnosis. 5th ed. St. Louis, USA: Elsevier; 2012. p. 2238. https://doi.org/10.1007/s12291-012-0287-7 DOI: https://doi.org/10.1007/s12291-012-0287-7
Friedewald WI, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502. https://doi.org/10.1093/clinchem/18.6.499 PMid:4337382 DOI: https://doi.org/10.1093/clinchem/18.6.499
Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Annal Biochem. 1979;95:351-8. https://doi.org/10.1016/0003-2697(79)90738-3 PMid:36810 DOI: https://doi.org/10.1016/0003-2697(79)90738-3
Thompson D, Huffman K, Kraus W, Kraus V. Critical appraisal of four IL-6 immunoassays. PLoS One. 2012;7(2):e30659-66. https://doi.org/10.1371/journal.pone.0030659 PMid:22347395 DOI: https://doi.org/10.1371/journal.pone.0030659
Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda H, Tsuruta O, et al. Soluble interleukin-6 receptors in inflammatorybowel disease: Relation to circulating interleukin-6. Gut. 1995;36:45-9. https://doi.org/10.1136/gut.36.1.45 PMid:7890234 DOI: https://doi.org/10.1136/gut.36.1.45
Moser SS, Chodick G, Bar-On S, Shalev V. Healthcare utilization and prevalence of symptoms in women with menopause: A real-world analysis. Int J Womens Health. 2020;12:445-54. https://doi.org/10.2147/ijwh.s246113 DOI: https://doi.org/10.2147/IJWH.S246113
Islam M, Gartoulla P, Bell R, Fradkin P, Davis S. Prevalence of menopausal symptoms in asianmidlife women: A systematic review. Climacteric. 2015;18(2):157-76. https://doi.org/10.3109/13697137.2014.937689 PMid:24978151 DOI: https://doi.org/10.3109/13697137.2014.937689
Brown D, Sievert L, Morrison L, Reza A, Mills P. Do Japanese American women really have fewer hot flashes than European Americans? The Hilo women’s health study. Menopause. 2009;16(5):870-6. https://doi.org/10.1097/gme.0b013e31819d88da PMid:19367185 DOI: https://doi.org/10.1097/gme.0b013e31819d88da
Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013;12:CD001395. https://doi.org/10.1002/14651858.cd001395.pub3 PMid:24323914 DOI: https://doi.org/10.1002/14651858.CD001395.pub3
Cheng PF, Chen JJ, Zhou XY, Ren YF, Huang W, Zhou JJ, et al. Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis. Menopause. 2015;22(2):198-206. https://doi.org/10.1097/gme.0000000000000290 PMid:25003621 DOI: https://doi.org/10.1097/GME.0000000000000290
Zhou X, Bi B, Zheng L, Li Z, Yang H, Song H, et al. The prevalence and risk factors for depression symptoms in a rural Chinese sample population. PLoS One. 2014;9(6):e99692. https://doi.org/10.1371/journal.pone.0099692 PMid:24919087 DOI: https://doi.org/10.1371/journal.pone.0099692
Abolfazl F. Effect of phytoestrogen on depression and anxiety in menopausal women: A systematic review. J Menopausal Med. 2017;23(3):160-5. https://doi.org/10.6118/jmm.2017.23.3.160 PMid:29354615 DOI: https://doi.org/10.6118/jmm.2017.23.3.160
Shahmohammadi A, Ramezanpour N, Siuki MM, Dizavandi F, Ghazanfarpour M, Rahmani Y, et al. The efficacy of herbal medicines on anxiety and depression in peri and postmenopausal women: A systematic review and meta-analysis. Post Reprod Health. 2019;25(3):131-41. https://doi.org/10.1177/2053369119841166 PMid:31630610 DOI: https://doi.org/10.1177/2053369119841166
Rahimikian F, Rahimi R, Golzareh P, Bekhradi R, Mehran A. Effect of Foeniculumvulgare Mill. (fennel) on menopausal symptoms in postmenopausal women. Menopause. 2017;24(9):1017-21. https://doi.org/10.1097/gme.0000000000000881 PMid:28509813 DOI: https://doi.org/10.1097/GME.0000000000000881
Ghazanfarpour M, Sadeghi R, Roudsari RL, Khorsand I, Khadivzadeh T, Muoio B. Red clover for treatment of hot flashes and menopausal symptoms: A systematic review and meta-analysis. J Obstet Gynaecol. 2016;36(3):301-11. https://doi.org/10.3109/01443615.2015.1049249 PMid:26471215 DOI: https://doi.org/10.3109/01443615.2015.1049249
El Shebini SM, Moaty MI, Fouad S, Kazem YM, Ahmed NH, Mohamed MS, et al. Association between serum clusterin and cognitive functions in obese Egyptian women; potential effects of dietary therapy. Pharm Chem. 2016;8(6):205-13.
Hilakivi-Clarke L, Andrade J, Helferich W. Is soy consumption good or bad for the breast? J Nutr 2010;140(12):2326S-34S. https://doi.org/10.3945/jn.110.124230 PMid:20980638 DOI: https://doi.org/10.3945/jn.110.124230
Bai W, Wang C, Ren C. Intakes of total and individual flavonoids by US adults. Int J Food Sci Nutr. 2014;65(1):9-20. PMid:24020353 DOI: https://doi.org/10.3109/09637486.2013.832170
Richard A, Rohrmann S, Mohler-Kuo M, Rodgers S, Moffat R, Güth U, et al. Urinary phytoestrogens and depression in perimenopausal US women. J Affect Disord. 2014;156:200-5. PMid:24434020 DOI: https://doi.org/10.1016/j.jad.2013.12.029
Messina M, Gleason C. Evaluation of the potential antidepressant effects of soybean isoflavones. Menopause. 2016;23(12):1348- 60. https://doi.org/10.1097/gme.0000000000000709 PMid:27552470 DOI: https://doi.org/10.1097/GME.0000000000000709
Cohen LS, Joffe H, Guthrie KA, Ensrud K, Freeman M, Carpenter J, et al. Efficacy of omega-3 for vasomotor symptoms treatment: A randomized controlled trial. Menopause. 2014;21(4):347-54. https://doi.org/10.1097/gme.0b013e31829e40b8 PMid:23982113 DOI: https://doi.org/10.1097/GME.0b013e31829e40b8
Ciappolino V, Mazzocchi A, Enrico P, Syrén M, Delvecchio G, Agostoni C, Brambilla P. N-3 polyunsatured fatty acids in menopausal transition: A systematic review of depressive and cognitive disorders with accompanying vasomotor symptoms. Int J Mol Sci. 2018;19(7):1849-63. https://doi.org/10.3390/ijms19071849 DOI: https://doi.org/10.3390/ijms19071849
Liao Y, Xie B, Zhang H, He Q, Guo L, Subramaniapillai M, et al. Efficacy of omega-3 PUFAs in depression: A meta-analysis. Transl Psychiatry. 2019;9(1):190. https://doi.org/10.1038/s41398-019-0515-5 PMid:31383846 DOI: https://doi.org/10.1038/s41398-019-0515-5
Lucas M, Asselin G, Mérette C, Poulin M, Dodin S. Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: A double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr. 2009;89(2):641-51. https://doi.org/10.3945/ajcn.2008.26749 PMid:19116322 DOI: https://doi.org/10.3945/ajcn.2008.26749
Yang JR, Han D, Qiao ZX, Tian X, Qi D, Qiu XH. Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: A meta-analysis of double-blind randomized controlled trials. Neuropsychiatr Dis Treat. 2015;11:2055-61. https://doi.org/10.2147/ndt.s86581 PMid:26300645 DOI: https://doi.org/10.2147/NDT.S86581
El Tanbouly N, El Sayed A, Ali Z, Abdel Wahab S, El Gayed SH, Ezzat SM, et al. Antidepressant-like effect of selected Egyptian cultivars of flaxseed oil on a rodent model of postpartum depression. Evid Based Complement Alternat Med. 2017;2017:6405789. https://doi.org/10.1155/2017/6405789 PMid:29333185 DOI: https://doi.org/10.1155/2017/6405789
Di L, Yongqing T, Yan L. Associations between dietary oleic acid and linoleic acid and depressive symptoms in perimenopausal women: The study of women’s health across the Nation. Nutrition. 2020;71:110602. https://doi.org/10.1016/j.nut.2019.110602 DOI: https://doi.org/10.1016/j.nut.2019.110602
Kurotani K, Sato M, Ejima Y, Kashima K, Nanri A, Minh N, et al. Serum alpha-linolenic and linoleic acids are inversely associated with depressive symptoms in adults. e-SPEN J. 2014;9:e7-12. https://doi.org/10.1016/j.clnme.2013.12.003 DOI: https://doi.org/10.1016/j.clnme.2013.12.003
Okereke O, Reynolds C, Mischoulon D, Chang G, Cook N, Copeland T, et al. The Vitamin D and OmegA-3 TriaL-depression endpoint prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating Vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. Contemp Clin Trials. 2018;68:133-45. https://doi.org/10.1016/j.cct.2018.02.017 PMid:29526608 DOI: https://doi.org/10.1016/j.cct.2018.02.017
Niharika M, Jyothi A. Natural phytoestrogen for menopause. J Environ Sci Toxicol Food Technol. 2013;5(1):15-7. https://doi.org/10.9790/2402-0511517 DOI: https://doi.org/10.9790/2402-0511517
Jones S, Takeuchi T, Aletaha D, Smolen J, Choy E, McInnes L. Interleukin 6: The biology behind the therapy. Considerations Med. 2018;2(1):2-6. https://doi.org/10.1136/conmed-2018-000005 DOI: https://doi.org/10.1136/conmed-2018-000005
Yamasaki K, Hasegawa T, Takeda M. Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder. Neuropsychopharmacol Rep. 2020;40(2):130-7. https://doi.org/10.1002/npr2.12100 PMid:32162496 DOI: https://doi.org/10.1002/npr2.12100
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Suzanne Fouad, Salwa M. El Shebini, Maha Abdel-Moaty, Nihad Hassan Ahmed, Ahmed Mohamed Saied Hussein, Hend Abbas Essa, Salwa T. Tapozada (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
